Pellegrino Musto. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Angiogenesis Inhibitors/therapeutic useClinical Trials, Phase II as TopicFemaleHumansMaleMyelodysplastic Syndromes/drug therapyThalidomide/therapeutic useTreatment Outcome
Substances: See more » Angiogenesis InhibitorsThalidomide
Year: 2007 PMID: 17279582 DOI: 10.1002/cncr.22516
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860